Lilly adds Alzheimer's to online offerings
1. Eli Lilly expands LillyDirect for Alzheimer's care, boosting Kisunla sales potential. 2. LillyDirect now includes telehealth, enhancing accessibility for Alzheimer's patients.
FAQ
Why Bullish?
The expansion of LillyDirect could significantly increase Kisunla's market penetration, similar to past drug rollout successes. Historical examples show that telehealth initiatives have led to increased sales in the pharmaceutical sector.
How important is it?
The expansion is likely to enhance drug accessibility, illustrating a strategic move that can positively influence LLY’s overall market position.
Why Long Term?
Once telehealth services gain traction, sales growth for Kisunla may continue to rise over years, akin to trends seen with other successful Alzheimer’s treatments.